Elaine Campbell

President of AstraZeneca Canada Inc.

Elaine Campbell

President of AstraZeneca Canada Inc.

Responsibilities

Elaine Campbell is President of AstraZeneca Canada Inc., one of Canada’s leading biopharmaceutical companies. She returned to Canada in 2012 after 16 years of living and working in the United States.

Prior experience

Elaine has more than 23 years experience in the biopharmaceutical industry, including twelve years with AstraZeneca PLC. Her last U.S.-based role was Commercial Brand Leader for the United States BRILINTA® team, where she launched the cardiovascular product in the U.S. market. Prior to this, she held a number of senior leadership roles within the Global Marketing organization including Vice President of Global Primary Care Brands and Vice President of Global Marketed Brands. Elaine has also led the launch of IRESSA® in the U.S. market, as well as the CRESTOR® Global Project Team, including both Commercial and Development groups for that brand.

Prior to joining AstraZeneca, Elaine was a Senior Vice President and member of the Business Operating Team with DuPont Pharmaceuticals, located in the U.S. During her tenure with DuPont Pharmaceuticals, she held various senior leadership roles within the sales and marketing functions in the U.S. and Canada.

Education

  • Bachelor of applied science in chemical engineering from University of Toronto
  • MBA from St. Joseph’s University, Philadelphia, PA

Affiliations

  • Rx&D (Canada’s Research-based Pharmaceutical Companies) Ontario Regional Committee: Chair
  • Advanced Coronary Treatment (ACT) Foundation: Board Member
  • MaRS (Medical and Related Sciences) Discovery District: Board Member
  • Advisory Board of the University of Toronto Department of Chemical Engineering: Member